Lecture 1 Management of Cervical Cancer
Lecture 1 Management of Cervical Cancer
Lecture 1 Management of Cervical Cancer
CERVICAL CANCER:
INTRODUCTION, EPIDEMIOLOGY
AND CLINICAL FEATURES
Ref: Torre LA, Bray F, Siegel RL, et al. Global Cancer Statistics, 2012. 2015;00(00):1-22
Worldwide:
5th after lung, breast, colorectal &
prostate ca
70% of CC
occur 4th after breast,
in low colorectal and lung
resourced cancer.
countries
2nd
after
Breast
Ca.
ASR is
Rate of CC highest among
1. Indian
increases after 30 (10.3/100,000)
2.Chinese
year old and peaked at (9.5/100,000)
3. Malay
65-69 year old (5.3/100,000))
ASR: age-standardised rate
Ref: NCR 2007
WHO IS HIGH RISK?
• Primary cause of cervical cancer is HPV
(human Papilloma Virus) which is transmitted sexually.
35
34.7
30
25 25.6
20 21
18.7
15
10
0
STAGE 1 STAGE 2 STAGE 3 STAGE 4
• Referral to gynaecologist/gynae-oncologist
clinic after abnormal cytology or symptoms
is important to establish prompt diagnosis
Time frame for Referral of abnormal
cytology to gynaecology clinic
Referral
Ref:
Sahu B etal. Prevalence of pathology in women attending colposcopy for post coital bleeding
with negative cytology. Arch Gynecol Obstet. 2007;276(5):471–3.
Algorithm 1:
Assessment
of Cervical
Cancer
Take Home Messages
1. Most cervical cancer patients are asymptomatic &
presented at late stage of disease, hence pap smear
screening is of utmost importance in early detection.
2. The common symptoms are postmenopausal bleeding,
vaginal discharge, post coital bleeding and abdominal
pain.
3. Appropriate and timely referral is important to establish
prompt diagnosis and management
Thank You